Oct 2 (Reuters) - Lannett Company Inc:
* Lannett receives two fda approvals for Lansoprazole delayed-release capsules usp, one each for full prescription and OTC
* Lannett Company Inc - co expect to commence marketing our prescription Lansoprazole delayed-release capsules product in next several months​ Source text for Eikon: Further company coverage: